Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.
Sun S, Li E, Zhao G, Tang J, Zuo Q, Cai L, Xu C, Sui C, Ou Y, Liu C, Li H, Ding Y, Li C, Lu D, Zhang W, Luo P, Cheng P, Gao Y, Tu C, Pitard B, Rosenecker J, Wang B, Liu Y, Zou Q, Guan S.
Sun S, et al. Among authors: rosenecker j.
Biomaterials. 2023 Jan;292:121907. doi: 10.1016/j.biomaterials.2022.121907. Epub 2022 Nov 18.
Biomaterials. 2023.
PMID: 36436305
Free PMC article.